Loading...
Printed on 7/20/2026
For informational purposes only. This is not medical advice.
The Vulnerable Elders Survey-13 (VES-13) is a validated screening instrument for older adults that combines age, self-rated health, physical-function difficulty, and functional disability items. It helps identify individuals at increased risk of functional decline, hospitalization, and mortality who may benefit from closer follow-up and proactive care planning.
Formula: VES-13 total is computed from age points, self-rated health, physical-function points, and functional-disability points; >=3 indicates vulnerability.
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
The VES-13 consists of 13 items spanning four domains. First, assign age points: 0 points for ages 65–74, 1 point for ages 75–84, and 3 points for age 85 and above. Second, score self-rated health: 0 points if the patient rates their health as excellent, very good, good, or fair; 1 point if they rate their health as poor. Third, identify physical function limitations using a series of questions about difficulty with six physical tasks (stooping/crouching/kneeling, lifting/carrying heavy objects, reaching above shoulder height, writing/handling small objects, walking a quarter mile, and heavy housework) plus six specific ADL activities (shopping, managing finances, light housework, preparing meals, bathing/showering, and walking). Each physical limitation domain adds points to the score.
For the functional disability component, ask whether the patient has received help with any of a series of activities (bathing, getting dressed, eating, getting in/out of chairs, walking, and using the toilet) over the past three months because of their health. Any ADL for which help was received adds to the disability score. The physical function difficulty score and functional disability score are summed along with age and health points to generate the VES-13 total. The maximum possible score is 10; a score of 3 or higher identifies vulnerability. The scoring algorithm gives greater weight to functional disability than to self-rated health, reflecting evidence that objective functional limitations are more predictive of adverse outcomes than subjective health ratings.
A VES-13 score below 3 indicates lower vulnerability; the patient may benefit from routine age-appropriate preventive care and monitoring but does not require urgent intensive assessment. A score of 3 or above identifies the patient as vulnerable — defined as having at least a four-fold increased risk of health deterioration, functional decline, and death over the following two years compared to non-vulnerable older adults. Positive screens should trigger a more comprehensive assessment of functional status, cognition, nutrition, social support, medications, and advance care planning. In oncology contexts, a positive VES-13 often prompts full Comprehensive Geriatric Assessment before initiating cancer treatment.
Medical oncologists, geriatric oncology teams, cancer nurses
The VES-13 is one of the most widely used tools in geriatric oncology for identifying older patients with cancer who are at elevated risk of treatment-related toxicity, functional decline, and poor outcomes. A positive VES-13 (score ≥3) triggers comprehensive geriatric assessment, which then guides treatment intensity decisions, dose adjustments, and supportive care planning. Major oncology organizations including ASCO recommend routine vulnerability screening in older adults with cancer, and VES-13 is among the validated tools endorsed for this purpose. Its brevity — administrable by non-geriatricians — makes it feasible in busy oncology practices.
Primary care physicians, family medicine nurses, nurse practitioners
VES-13 can be administered as part of annual wellness visits for adults 65 and older to identify those who may need more intensive follow-up and proactive care coordination. It takes 5–10 minutes to complete and can be incorporated into pre-visit questionnaires or completed by medical assistants during rooming. Positive screens in primary care prompt closer surveillance, medication review, specialist referrals, and discussions about advance directives. The tool is sensitive enough to identify vulnerability before clinical deterioration occurs, enabling preventive rather than reactive care.
Surgeons, anesthesiologists, pre-operative assessment nurses
In perioperative settings, VES-13 helps rapidly identify older surgical candidates who require more thorough pre-operative optimization. Patients with positive VES-13 scores before elective surgery have higher rates of post-operative complications, longer hospital stays, and greater likelihood of discharge to rehabilitation or skilled nursing facilities rather than home. The VES-13 can be included in pre-operative patient questionnaires or administered at anesthesia pre-assessment clinics, with positive screens triggering geriatric medicine consultation for optimization before elective procedures.
Cardiologists, heart failure specialists, cardiac rehabilitation teams
In older adults with cardiovascular disease — particularly heart failure, atrial fibrillation, and coronary artery disease — vulnerability assessment with VES-13 helps predict adverse outcomes and guides the intensity of management. Vulnerable patients (VES-13 ≥3) with heart failure are at higher risk of readmission, functional decline, and death, and may benefit from more intensive community support, early specialist follow-up, and simplified medication regimens. The tool's focus on physical function limitations resonates with cardiologists, as functional capacity is a central concern in cardiovascular management.
Discharge planners, transitional care nurses, case managers
The VES-13 is useful during care transitions — particularly at hospital discharge — to identify patients who need intensive follow-up rather than routine primary care referral. Patients with VES-13 ≥3 at discharge are more likely to experience 30-day readmission and functional decline, making them appropriate targets for transitional care programs, home health referrals, and early post-discharge telephone follow-up. Administering VES-13 at discharge risk stratification takes only a few minutes but substantially improves prediction of which patients need proactive post-discharge support.
Neurologists, memory clinic coordinators, cognitive assessment nurses
In memory clinics and neurology services serving older adults, VES-13 provides a broader vulnerability snapshot beyond cognitive testing alone. Patients with cognitive complaints often have co-existing functional limitations, social vulnerability, and physical health deficits that amplify their overall risk profile. A positive VES-13 in someone presenting with mild cognitive complaints suggests a higher overall frailty burden and may support more intensive follow-up, social work involvement, and early advance care planning discussions.
The VES-13 is designed for patient self-completion and can be embedded in pre-visit questionnaires or mailed ahead of scheduled appointments. When patients complete it independently or with minimal assistance at home, the score reflects their typical daily functional status rather than performance during a clinical visit, which may be affected by anxiety, pain, or effort. Pre-visit completion also saves consultation time and allows the clinician to review the score and domain breakdown before entering the room.
Because age 85 and above contributes 3 points — the largest single contribution to the VES-13 — many patients in this age group will reach the vulnerability threshold of 3 even without significant functional limitation. Clinicians should interpret high scores in the very oldest-old with awareness that age alone is driving a substantial proportion of the risk. The tool intentionally assigns higher weight to advanced age because it is itself a strong independent predictor of adverse outcomes; this is not a flaw but a deliberate calibration choice.
Self-rated health has robust evidence as an independent predictor of mortality and hospitalization across all age groups. When a patient rates their health as 'poor' (as opposed to fair, good, very good, or excellent), this carries prognostic significance beyond what objective clinical measurements can capture. Poor self-rated health reflects the patient's integrated perception of their overall health trajectory, symptom burden, functional limitations, and psychosocial wellbeing — and should prompt a thorough review of unmet needs even when objective markers appear relatively stable.
The VES-13 does not include a cognitive assessment domain, which means patients with early dementia may screen negative if their physical function and self-rated health appear normal. For a more complete vulnerability profile, pair VES-13 with a brief cognitive screen such as the [Mini-Cog](/tools/mini-cog) or AD8. A patient who screens negative on VES-13 but has cognitive impairment on Mini-Cog requires the same level of follow-up as a VES-13 positive screen in terms of care planning and safety assessment.
In primary care and specialist settings with limited access to comprehensive geriatric assessment, VES-13 provides an objective, standardized basis for prioritizing geriatric medicine referrals. Patients with VES-13 scores of 6 or above have significantly higher risk of functional decline and death and should be prioritized for expedited geriatric assessment. Patients with scores of 3–5 can be managed initially with targeted primary care follow-up, with geriatric referral reserved for those who do not improve with initial interventions.
The specific physical tasks the patient reports difficulty with on VES-13 identify the functional domains at greatest risk. Difficulty with stooping, crouching, or kneeling suggests lower extremity weakness and fall risk; difficulty writing or handling small objects may indicate upper extremity dysfunction or neurological changes; difficulty walking a quarter mile identifies reduced exercise tolerance and cardiovascular deconditioning. These specific functional deficits can guide targeted physiotherapy or occupational therapy referral, home safety assessment, and adaptive equipment planning.
Unlike some frailty tools where a single positive domain triggers the same clinical response, VES-13 score is additive — each additional point increases the risk of adverse outcomes. A score of 7 does not confer the same level of risk as a score of 3, and patients with the maximum score of 10 have substantially higher short-term risk than those at threshold. Communicating the numeric score (not just positive/negative) to patients and their families helps frame the urgency of recommended interventions.
The VES-13 was designed specifically to detect vulnerability in community-dwelling older adults, which is a somewhat broader concept than phenotypic frailty. It identifies people at elevated risk of functional decline and death rather than diagnosing physical frailty syndrome. This means it will be positive in some patients who are not frail by Fried criteria — particularly very old patients with a single significant functional limitation — which is intentional and clinically appropriate for its screening purpose.
VES-13 developed by Saliba D et al. (J Am Geriatr Soc 2001) in a community-based Medicare population (n=16,512); score ≥3 associated with 4.2-fold increased risk of functional decline and death over 2 years. Oncology validation: Mohile SG et al. (J Clin Oncol 2007). ASCO guideline endorsement for geriatric assessment in older cancer patients. Self-report format validated against clinician-administered version with high concordance.
Higher VES-13 scores indicate higher vulnerability and risk of functional decline, supporting intensified follow-up and proactive geriatric care planning.
Use in adults aged 65+ for rapid triage in primary care, oncology, perioperative pathways, and transitional care settings.
VES-13 is a screening framework and does not replace direct performance testing or comprehensive geriatric assessment.
For related assessments, see Lawton IADL, Katz ADL and Clinical Frailty Scale.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Assess independence in higher-level daily tasks using the Lawton IADL scale (score 0-8).
OpenGeriatricsAssess independence in six basic activities of daily living with the Katz ADL Index. Scores range from 0 (dependent) to 6 (fully independent).
OpenGeriatricsAssess frailty using the Rockwood Clinical Frailty Scale (CFS 1–9): Very Fit to Terminally Ill. Used for hospice eligibility, prognostication, ICU triage, surgical risk stratification, and goals-of-care discussions.
OpenGeriatricsScreen frailty with the 7-item PRISMA-7 questionnaire (score 0-7; >=3 suggests frailty risk).
Open